Clinical trial
S0500 Treatment Decision Making Based on Blood Levels of Tumor Cells for…
NCT00382018 · SWOG Cancer Research Network, Other · Completed
Key facts
| NCT number | NCT00382018 |
|---|---|
| Title | S0500 Treatment Decision Making Based on Blood Levels of Tumor Cells for Metastatic Breast Cancer Treated With Chemo |
| Official title | A Randomized Phase III Trial to Test the Strategy of Changing Therapy Versus Maintaining Therapy for Metastatic Breast Cancer Patients Who Have Elevated Circulating Tumor Cell Levels at First Follow-Up Assessment |
| Lead sponsor | SWOG Cancer Research Network, Other |
| Collaborators | National Cancer Institute (NCI) NIH Cancer and Leukemia Group B |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | chemotherapy |
| Enrollment | 624 |
| Start date | Oct 1, 2006 |
| Primary completion | Dec 1, 2015 |
| Completion | Jul 11, 2017 |
| First posted | Sep 28, 2006 |
| Last update posted | Nov 6, 2017 |
| Countries | United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: